Molecular therapy for Psoriasis: NR2F2 decreases psoriasiform skin inflammaiton via down regulation of its target gene., 25/Septmber/2014, 06.47 am

Therapeutic insights into the treatment of Sickle cell disease and β-thalassemias: Ras Responsive Element Binding Protein 1 (RREB) decreases sickling of erythrocytes via up regulation of fetal HbF, 25/September/2014, 06.41 am
September 25, 2014
Therapeutic insights into increasing the life expectancy of an individual: AntagomiR-218 increases male life span via down regulation of its target gene, 24/September/2014, 06.56 am
September 25, 2014
Show all

A recent study from the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; and Institute for Biomedical Research, University College London, London, UK shows that Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.” This study was published in the Apr 23  2014 Nature by Prof Ulrich H. von AndrianLorena Riol-Blanco, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Molecular therapy for Psoriasis: NR2F2 decreases psoriasiform skin inflammaiton via down regulation of its target gene. This study suggests that NR2F2, by increasing the expression of its target gene, it may alleviate the interleukin-23-mediated psoriasiform skin inflammationTogether, this study suggests that pharmacological formulations encompassing “NR2F2  or its activators” may be used to treat psoriasiform skin inflammation.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L., Molecular therapy for Psoriasis: NR2F2 decreases psoriasiform skin inflammaiton via down regulation of its target gene., 25/Septmber/2014, 06.47 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.